Earnings
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Proceeds will be used to assemble and develop a diversified pipeline of therapies to address sight-threatening illnesses.
Prescription drug costs have continued to rise, with more than 150 drug manufacturers raising their prices in January.
The strategic collaboration centers on Remix’s REMaster platform for the discovery and development of small molecule therapies that modulate RNA processing.
Biopharma and life sciences companies from across the globe provide updates to their pipelines and businesses.
TenSixteen Bio recently came out of stealth mode with $40 million in funding to target somatic mosaicism – particularly clonal hematopoiesis of indeterminate potential (CHIP).
Kallyope focuses on the gut-brain axis, a bi-directional communication between the gastrointestinal tract and the brain.
Terray Therapeutics has generated $60 million from a Series A financing round just shortly after getting $20 million in seed funding for the AI drug discovery.
The three-year agreement leverages AvantGen’s yeast display technology for antibody discovery optimization to engineering antibodies into Antibody-Drug Conjugate treatments.
The grant is the latest in a steady stream of company advances highlighted by the addition of a chief financial officer in January and several collaborative agreements in the past year.
PRESS RELEASES